Comparative Pharmacology
Head-to-head clinical analysis: DIALYTE LM DEXTROSE 4 25 IN PLASTIC CONTAINER versus INPERSOL ZM W DEXTROSE 4 25 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIALYTE LM DEXTROSE 4 25 IN PLASTIC CONTAINER versus INPERSOL ZM W DEXTROSE 4 25 IN PLASTIC CONTAINER.
DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER vs INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Removes waste products (e.g., urea, creatinine) and excess electrolytes via diffusion and ultrafiltration across the peritoneal membrane; dextrose acts as osmotic agent to generate ultrafiltration.
Provides osmotic gradient for peritoneal dialysis; glucose and icodextrin facilitate ultrafiltration and removal of waste products across the peritoneal membrane.
Intraperitoneal administration: 2 to 2.5 liters per exchange, 4 to 5 exchanges daily, as part of continuous ambulatory peritoneal dialysis (CAPD).
2 L intraperitoneally via an indwelling peritoneal catheter, dwell time 4-6 hours, 4 exchanges per day
None Documented
None Documented
Not applicable; dextrose is rapidly metabolized (half-life ~2-5 min), electrolytes are distributed and excreted renally with half-life dependent on renal function.
Not applicable as a traditional half-life; removal is dependent on peritoneal dialysis dwell time and membrane transport characteristics. Effective clearance half-life during dialysis is approximately 2-4 hours depending on exchange schedule.
Renal: 100% (electrolytes and dextrose are completely reabsorbed or metabolized; water is excreted renally). Biliary/fecal: 0%.
Primarily removed via peritoneal dialysis; minimal renal excretion (less than 5% unchanged). Dextrose is metabolized to CO2 and water. Biliary/fecal excretion negligible.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution